Arnuity ellipta and Hyperhidrosis - a phase IV clinical study of FDA data

Summary:

Hyperhidrosis is reported as a side effect among people who take Arnuity ellipta (fluticasone furoate), especially for people who are female, 60+ old, also take Carvedilol, and have Asthma.

The phase IV clinical study analyzes which people have Hyperhidrosis when taking Arnuity ellipta. It is created by eHealthMe based on reports of 3,456 people who have side effects when taking Arnuity ellipta from the FDA, and is updated regularly.

What is Arnuity ellipta?

Arnuity ellipta has active ingredients of fluticasone furoate. eHealthMe is studying from 3,482 Arnuity ellipta users. Check the latest studies of Arnuity ellipta.

What is Hyperhidrosis?

Hyperhidrosis (abnormally increased sweating) is found to be associated with 2,549 drugs and 3,547 conditions by eHealthMe. Check the latest studies of Hyperhidrosis.

On Aug, 06, 2026

3,456 people reported to have side effects when taking Arnuity ellipta.
Among them, 14 people (0.41%) have Hyperhidrosis.

Could Arnuity ellipta cause Hyperhidrosis?

Among these 14 people:

What is the gender of people who have Hyperhidrosis when taking Arnuity ellipta? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Hyperhidrosis when taking Arnuity ellipta? *

What are other drugs people take besides Arnuity ellipta? *

Lisinopril: 3 people, 21.43%
Amlodipine: 3 people, 21.43%
Prednisone: 3 people, 21.43%
Zomig: 3 people, 21.43%
Symbicort: 3 people, 21.43%
Imvexxy: 3 people, 21.43%
Atrovent: 3 people, 21.43%
Ventolin: 3 people, 21.43%
Vilazodone Hydrochloride: 3 people, 21.43%
Carvedilol: 3 people, 21.43%

What are other side effects people have besides Hyperhidrosis? *

Nausea (feeling of having an urge to vomit): 6 people, 42.86%
Cough: 6 people, 42.86%
Dyspnea Exertional: 5 people, 35.71%
Dyspnea (difficult or laboured breathing): 5 people, 35.71%
Dizziness: 5 people, 35.71%
Sleep Disorder: 4 people, 28.57%
Weakness: 4 people, 28.57%
Gastroenteritis Viral (inflammation of stomach and intestine caused by virus infection): 3 people, 21.43%
Forced Expiratory Volume Abnormal (abnormal lung expired air volume): 3 people, 21.43%
Nervousness: 3 people, 21.43%

What are the existing conditions these people have? *

Asthma: 5 people, 35.71%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 21.43%
Ovarian Cancer (cancer of ovary): 2 people, 14.29%
Urticaria Pigmentosa (skin disease that produces patches of darker skin (lesions) and very bad itching): 1 person, 7.14%
Immune System Disorder: 1 person, 7.14%
Hypergammaglobulinaemia (elevated levels of gamma globulin): 1 person, 7.14%
Drowsiness: 1 person, 7.14%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 7.14%
Angioedema (rapid swelling of the dermis): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Arnuity ellipta and have Hyperhidrosis?

- Check whether Hyperhidrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Arnuity ellipta:

Arnuity ellipta (3,482 reports)

Hyperhidrosis treatments and more:

Hyperhidrosis (147,206 reports)

Browse all side effects of Arnuity ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperhidrosis:

Hyperhidrosis (2,549 drugs)

Browse all the conditions that are associated with Hyperhidrosis:

Hyperhidrosis (3,547 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone furoate (the active ingredients of Arnuity ellipta) and Arnuity ellipta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.